Research Article
Identification of MAN1B1 as a Novel Marker for Bladder Cancer and Its Relationship with Immune Cell Infiltration
Table 2
Univariate and multivariate analysis of OS in BLCA patients.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| T stage | 379 | | | | | T1 & T2 | 124 | Reference | | | | T3 | 195 | 1.997 (1.358–2.939) | <0.001 | 1.975 (1.019–3.826) | 0.044 | T4 | 60 | 3.095 (1.934–4.954) | <0.001 | 2.572 (1.154–5.732) | 0.021 |
| N stage | 369 | | | | | N0 | 239 | Reference | | | | N1 | 46 | 1.858 (1.199–2.879) | 0.006 | 1.634 (0.850–3.142) | 0.141 | N2 & N3 | 84 | 2.581 (1.828–3.646) | <0.001 | 2.176 (1.206–3.928) | 0.010 |
| M stage | 213 | | | | | M0 | 202 | Reference | | | | M1 | 11 | 3.136 (1.503–6.544) | 0.002 | 1.028 (0.381–2.777) | 0.956 |
| MAN1B1 | 413 | | | | | Low | 207 | Reference | | | | High | 206 | 1.728 (1.286–2.323) | <0.001 | 1.970 (1.226–3.167) | 0.005 |
| Age | 413 | | | | | <=70 | 233 | Reference | | | | >70 | 180 | 1.421 (1.063–1.901) | 0.018 | 1.292 (0.804–2.075) | 0.289 |
| Gender | 413 | | | | | Female | 109 | Reference | | | | Male | 304 | 0.849 (0.616–1.169) | 0.316 | | |
|
|